Biosurgery Market 2022: Size, Share, Trends, Outlook and Forecast 2027

According to the latest report by IMARC Group, titled “Biosurgery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” The global biosurgery market reached a value of US$ 12.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 18.2 Billion by 2027, exhibiting a CAGR of 6.95% during 2022-2027.

Biosurgery is a medical procedure that uses natural, synthetic, or semi-synthetic materials to seal surgical incisions and wounds. It is extensively utilized to prevent excessive blood loss, provide adhesion for wound or tissue sealing, repair damaged bones and tissues, etc. Biosurgeries are generally conducted through hemostatic, sealant, bone graft substitute, adhesion prevention, soft tissue repair, and staple line reinforcement products. They also use natural allografts, xenografts, and cultured epithelial autografts to minimize intra- and post-operative complications and promote faster recovery of patients. Consequently, biosurgical processes are widely adopted in several surgeries, including neurological, orthopedic, spinal, reconstruction, thoracic, cardiovascular, etc.

Request for a free sample copy of this report: https://www.imarcgroup.com/biosurgery-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Market Trends:

The escalating incidences of musculoskeletal disorders are primarily driving the biosurgery market. Moreover, the expanding geriatric population, who are more prone to chronic medical ailments, such as osteoporosis, is further catalyzing the market growth. Besides this, numerous healthcare providers are increasingly adopting biosurgeries for effectively managing blood loss in patients with surgical sealants and minimally invasive (MI) hemostatic agents instead of conventionally used sutures and staples. This, in turn, is acting as another significant growth-inducing factor. Furthermore, the growing incidences of sports-related injuries and accidental traumas are also augmenting the global market. Apart from this, the development of plasma-based, multi-functional, and multi-use products for these surgical processes is anticipated to stimulate the biosurgery market in the coming years.

Breakup by Product:

• Bone-Graft Substitutes
• Soft-Tissue Attachments
• Hemostatic Agents
• Surgical Sealants and Adhesives
• Adhesion Barriers
• Staple Line Reinforcement

Breakup by Source:

• Natural/Biologics Products
• Synthetic Products

Breakup by Application:

• Orthopedic Surgery
• General Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Gynecological Surgery
• Others

Breakup by End User:

• Hospitals
• Clinics
• Others

Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Competitive Landscape with Key Player:

• B. Braun Melsungen AG
• Baxter International Inc
• Becton Dickinson and Company
• CryoLife Inc
• CSL Limited
• Hemostasis LLC
• Integra Lifesciences Holdings Corporation
• Johnson & Johnson
• Medtronic plc
• Pfizer Inc
• Sanofi S.A
• Smith & Nephew plc
• Stryker Corporation
• Surgalign Spine Technologies Inc

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/biosurgery-market

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800